LTAS
NVO

Linden Thomas Advisory Services’s Novo Nordisk NVO Stock Holding History

Linden Thomas Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,011
Closed -$279K – 493
2025
Q1 		$279K Buy
4,011
+456
+13% +$37.7K 0.04% 424
2024
Q4 		$306K Buy
3,555
+726
+26% +$78.5K 0.04% 430
2024
Q3 		$337K Buy
2,829
+566
+25% +$75.5K 0.05% 410
2024
Q2 		$323K Buy
2,263
+360
+19% +$47.7K 0.05% 396
2024
Q1 		$244K Sell
1,903
-166
-8% -$19.8K 0.04% 399
2023
Q4 		$214K Buy
+2,069
New +$205K 0.04% 402

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Linden Thomas Advisory Services's NVO Position: Q2 2025 in Review

Linden Thomas Advisory Services sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 4,011 shares — an estimated $279K sold.

Linden Thomas Advisory Services first reported a position in NVO in Q4 2023 and held it in 6 quarters. The position peaked at $337K in Q3 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Linden Thomas Advisory Services reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Linden Thomas Advisory Services sold 4,011 Novo Nordisk shares in Q2 2025, an estimated $279K.
  • Linden Thomas Advisory Services first reported a position in Novo Nordisk in Q4 2023 and held it in 6 quarters.
  • Linden Thomas Advisory Services's Novo Nordisk position peaked at $337K in Q3 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2025, filed 31 Jul 2025.